MTOR inhibitors: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 December 2023

  • curprev 15:1415:14, 16 December 2023Ai talk contribs 3,090 bytes +3,090 Created page with "== Introduction == mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR), which is a serine/threonine-specific protein kinase that belongs to the family of phosphatidylinositol-3 kinase (PI3K) related kinases (PIKKs). These inhibitors have significant therapeutic potential in a variety of diseases, including cancer, cardiovascular disease, and autoimmune disorders. Image:Detail-56124.jpg|thumb|center|A close-up view of mTOR inhi..."